Medicamen Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Medicamen Biotech	Medico Remedies	Zim Laboratories
Operational Metrics
Financials
5 yr Average ROE	6.92 %	13.93 %	7.41 %
5yr average Equity Multiplier	1.44	2.07	1.88
5yr Average Asset Turnover Ratio	0.55	1.49	0.94
5yr Avg Net Profit Margin	8.69 %	4.73 %	4.15 %
Price to Book	1.24	4.73	1.46
P/E	36.14	27.24	52.56
5yr Avg Cash Conversion Cycle	49.75 Days	53.33 Days	37.07 Days
Inventory Days	84.58 Days	48.95 Days	68.72 Days
Days Receivable	139.4 Days	129.15 Days	99.71 Days
Days Payable	264.75 Days	124.28 Days	143.26 Days
5yr Average Interest Coverage Ratio	7.03	11.55	3.96
5yr Avg ROCE	10.34 %	20.03 %	13.52 %
5yr Avg Operating Profit Margin	15.51 %	7.11 %	12.21 %
5 yr average Debt to Equity	0.15	0.26	0.39
5yr CAGR Net Profit	-11.57 %	31.26 %	10.7 %
5yr Average Return on Assets	4.73 %	6.88 %	4.02 %
Shareholdings
Promoter Holding	40.46 %	61.38 %	33.26 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.75 %	-11.96 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Medicamen Biotech	Medico Remedies	Zim Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals Formulations 100.0 Traded Goods 0 Manufactured Goods 0 Pharma 0	Product Wise Break-Up Pharma 0 Manufactured Goods 96.53 Pharmaceuticals Formulations 0 Traded Goods 1.96 Others 1.51	Product Wise Break-Up Pharmaceutical 100.0 Manufactured Goods 0 Pharmaceuticals Formulations 0 Traded Goods 0
Location Wise Break-Up	Location Wise Break-Up India 20.0 Outside India 0 MENA 0 Asia (Ex India) 0 Africa 0 Others 80.0	Location Wise Break-Up Outside India 89.6 Asia (Ex India) 0 MENA 0 Africa 0 India 10.4	Location Wise Break-Up Outside India 0 Asia (Ex India) 25.0 Middle East 39.0 Africa 9.0 India 17.0 Others 10.0